#None #Securities Fraud #Pomerantz LLP #Chemours Company

Pomerantz Law Firm Initiates Class Action Lawsuit Against Chemours Company

Pomerantz LLP, a renowned law firm specializing in corporate and securities litigation, has announced the filing of a class action lawsuit against The Chemours Company and several of its officers. The lawsuit was filed in the United States District Court for the District of Delaware and is recorded under the docket number 26-cv-01299. This legal action aims to represent a class including all individuals and entities who acquired Chemours securities from February 20, 2026, to August 4, 2026, seeking to recover losses resulting from alleged violations of federal securities laws by Chemours and its executives.

Allegations Against Chemours

The principal allegations center on the assertion that Chemours misled investors regarding important aspects of its business operations and prospects. Specifically, the complaint suggests that Chemours made materially false statements, leading investors to believe in higher demand for its products than was substantiated. Key claims include significant overstatements concerning the demand for Chemours' Opteon refrigeration chemicals, which are central to its Thermal Specialized Solutions segment.

During the class period, the firm allegedly indicated that growth in this segment was buoyed by legislation like the U.S. AIM Act, which purportedly supports a transition to environmentally-friendly refrigerants. However, the complaint asserts that Chemours failed to disclose that actual demand was declining, primarily due to overselling its initial stock of Opteon products in the previous year, which has since negatively impacted their financial forecasts.

Impact of the Class Period Update

The situation escalated on August 4, 2026, when Chemours reported its financial outcomes for the second quarter of that year. In this announcement, the company significantly adjusted its full-year adjusted EBITDA guidance down to $775 million to $825 million from an earlier range of $800 million to $900 million. This substantial guidance reduction indicated serious flaws in their prior financial outlook.

Company management also revealed issues related to the inventory strategy, informing shareholders that the past fiscal year had resulted in excessive inventory levels, which would affect sales moving forward. The implications of these revelations were damaging to investor confidence, exemplified by an immediate decline in Chemours' stock price of $3.34, which represented an 18.63% drop on August 5, 2026, closing at $14.59 per share.

Investor Participation in the Class Action

Investors who acquired Chemours securities during the specified class period are encouraged to act quickly, as they have until December 7, 2026, to request the court designate them as Lead Plaintiff in this class action suit. Interested parties can access a copy of the complaint and learn further details at Pomerantz LLP's official website.

About Pomerantz LLP

Founded over 85 years ago by Abraham L. Pomerantz, a prominent figure in the realm of class action litigation, Pomerantz LLP has built a reputation as a leading firm dedicated to defending the rights of investors affected by securities fraud and corporate misconduct. The firm has successfully recovered billions in damages for its clients. Their expertise in handling complex litigation continues to protect the interests of investors facing corporate malfeasance.

For more information or inquiries regarding this class action lawsuit, investors may contact Danielle Peyton at Pomerantz LLP via email or phone. Interested parties are also encouraged to provide their details, including mailing addresses and information on shares purchased, to facilitate their participation in this significant legal action.

Conclusion

The initiation of this class action against Chemours underscores the importance of transparency and accountability in corporate governance, particularly for companies involved in critical markets like industrial and specialty chemicals. As the litigation unfolds, those affected by these developments will be watching closely for updates and the potential for recovery of their investments.